MedTrace Logo

Laparoscopic Resection of Large Gastric Stromal Tumors

NCT02662478 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2016-02-04

No results posted yet for this study

Summary

Despite laparoscopic surgical treatment has not been recommended in patients with gastric gastrointestinal stromal tumors (GIST) larger than 5 centimeter, but it continues to evolve rapidly to overcome the boundaries. Therefore the authors generated a morpho-anatomical classification system (MACS) adapted for primary gastric GISTs, by which they could plan to tailor the laparoscopic gastric resection appropriately. The aims of the study was to demonstrate the feasibility of laparoscopic surgery for primary gastric GISTs larger than 5 cm, to find out the accuracy and practicality of the MACS for the development a preoperative strategy and the extent to which this strategy overlaps with the reality.

Conditions

Interventions

PROCEDURE

Laparoscopic Surgery

Mid-point between the xiphoid and umbilicus was used to the entrance site of the telescope. Open trocar insertion was used in patients with history of open upper abdominal surgery; otherwise Veress needle established CO2 insufflations. The number, size and entry points of the other trocars were tailored according to the tumor location and size. In general, 2 to 4 additional trocars were used. All specimens were taken out of the abdomen through a suprapubic transverse incision in a sterile bag. Resection technique was determined by the size, number, location of the lesion, and surgical anatomy of the stomach. Lymph node dissection was not done as it is unnecessary.

Sponsors & Collaborators

  • Bahçeşehir University

    collaborator OTHER

  • Muğla Sıtkı Koçman University

    collaborator OTHER

  • Medical Park Gaziantep Hospital

    lead OTHER

Principal Investigators

  • Mehmet Kaplan, M.D. · Bahçeşehir Üniversitesi Tıp Fakültesi

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2016-01-31
Completion
2016-02-29

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02662478 on ClinicalTrials.gov